Low‐dose desoxycorticosterone pivalate treatment of hypoadrenocorticism in dogs: A randomized controlled clinical trial

BACKGROUND: Desoxycorticosterone pivalate (DOCP) is a commonly used mineralocorticoid replacement for dogs with primary hypoadrenocorticism (HA), but manufacturer‐recommended dosing protocols can be cost‐prohibitive. Recent reports also have raised concerns that label dose protocols could be excessi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Vet Intern Med
Asıl Yazarlar: Vincent, Alysha M., Okonkowski, Linda K., Brudvig, Jean M., Refsal, Kent R., Berghoff, Nora, Olivier, N. Bari, Langlois, Daniel K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Inc. 2021
Konular:
SMALL ANIMAL
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8295656/
https://ncbi.nlm.nih.gov/pubmed/34114259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.16195
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller